100
Participants
Start Date
February 19, 2020
Primary Completion Date
February 19, 2026
Study Completion Date
February 19, 2026
Cross-sectional imaging
MRI with gadolinium contrast will be the imaging modality of choice. In patients with contraindications to MRI who instead undergo baseline evaluation by CT scan, tumor evaluation will be by serial CT scans with IV contrast throughout the study period.
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center
OTHER